The Next Big Brain Cancer Drug Could Come from Marijuana

Sy Mukherjee 9:44 PM Central GW Pharmaceuticals (gwph, +2.63%) is already well on its way to winning the first-ever U.S. approval for a cannabis-derived therapy. But an early trial suggests that these treatments could also be an effective way to fight one of most devastating forms of brain cancers: glioblastoma multiforme. The U.K.-based company unveiled …